tabel kuma pneumoniiiiiiiiiiiiiiiiiiiiiiiii.pptx
- 1. Variables Resistance n = 55 Not Resistance n = 29 OR p CC Age 0.127 Sex 0.766 Lenght of Stay 0.000* 0.365 18.50 Clinical Outcome 0.233 Stroke 0.466 Comorbid Hipertensi 0.608 Diabetes Melitus 0.004* 0.302 5.208 Complications Sepsis 0.756 Syok Septik 0.049* 0.202 2.529
- 2. Bacteriae Isolate Acinetobacter baumannii 12 candida albicans 10 candida non albicans 2 Escherichia coli 4 Klebsiella pneumoniae 9 Pantoea agglomerans 1 Pseudomonas aeruginosa 15 Stahpylococcus cohni ssp urealyticum 1 Staphylococcus aureus 2 Staphylococcus epidermidis 4 Staphylococcus haemolyticus 4 Staphylococcus hominis 2 Stenotrophomonas maltophilia 1 steril 12 Culture not performed 5 Total 84
- 3. Variables Freq % Mean Median Age 60.86 ± 12.4 62 (18 – 85) Sex ? Women ? Men 44 40 51.9 48.1 Lenght of Stay 13.68 8.5 (1-88) Clinical Outcome ? Live ? Death 3 81 3.6 96.4 Stroke ? Cerebral Infarction ? Cerebral Haemorrgahe 48 36 57.1 42.9 Comorbid ? Hypertension ? Diabetes Melitus ? Covid ? Carcinoma ? Renal Failure ? COPD 70 55 9 4 9 2 83.3 73.8 10.7 4.8 10.7 2.4 Complication ? Sepsis ? Septic Shock 62 24 73.8 28.5
- 4. Jenis Resistensi Freq % CRAB 1 1 CRO 1 1 ESBL 12 11.5 MDRO 8 7.7 MRCoNS 22 21.2 MRSE 4 3.8 PDR 13 12.5 Vankomisin Resistent 1 1 XDR 4 3.8
- 5. Antibiotik Empiris Definitif Total penggunaan Ampisilin Sulbaktam 38 3 41 Levofloksasi n 15 0 15 Amikacin 32 18 50 Ceftriaxon 8 0 8 Ciprofloksasi n 9 2 7 Gentamicin 0 0 0 Meropenem 57 19 76 Moxofloksas in 21 2 23 Ceftazidime 0 1 1 Cefepime 0 1 1 Cefoperazon e 0 0 1 Vankomisin 0 6 6 Piperacilin 1 2 3 Azitromicin 1 0 1